11.05.2014 Views

2013 Apr 15 Annual Report 2012 - Phosphagenics

2013 Apr 15 Annual Report 2012 - Phosphagenics

2013 Apr 15 Annual Report 2012 - Phosphagenics

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Directors’ <strong>Report</strong> continued<br />

REMUNERATION REPORT (AUDITED) (CONTINUED)<br />

The Group’s current remuneration policies provide a signifi cant degree of linkage between an executive’s<br />

variable long term incentive remuneration and the overall fi nancial performance of the Group. Given the<br />

position of the Group and its stage of development, the remuneration is aimed at retaining key individuals<br />

to ensure the success of current and future product development and successful commercialisation<br />

of products, which will in turn impact future profi tability of the Group and shareholder wealth.<br />

Employment contracts<br />

No executives have fi xed term contracts with the Group. The company or the executive may terminate<br />

employment by providing four weeks written notice. On termination, any long term incentive plan<br />

(ESOP) options or (ECRS) rights that have vested are available to be exercised. Any options or rights<br />

that have not yet vested will be forfeited.<br />

The company may terminate employment at any time without notice if serious misconduct has<br />

occurred. Where termination with cause occurs the executive is only entitled to that portion<br />

of remuneration that is fi xed, and only up to the date of termination. On termination with cause,<br />

any unvested options or rights will immediately be forfeited.<br />

Company performance and its link to long-term incentives<br />

The fi nancial performance measures driving long-term incentive vesting and payment outcomes are<br />

revenues from the sale of goods and Company share price. Because of the stage of the Company’s<br />

development, earnings per share and other profi tability based measures do not accurately refl ect<br />

performance over the past fi ve years.<br />

The following chart shows <strong>Phosphagenics</strong> Limited’s annual revenues from the sale of goods and year<br />

end share price over the fi ve-year period from 1 January 2008 to 31 December <strong>2012</strong>.<br />

39<br />

3.0<br />

Company Performance 2008 to <strong>2012</strong><br />

2.5<br />

2.0<br />

1.5<br />

1.0<br />

0.5<br />

0.0<br />

2008<br />

2009<br />

2010<br />

2011<br />

<strong>2012</strong><br />

Revenue from sale of goods<br />

31 December Share Price<br />

Options granted during the year to key management personnel<br />

No options were awarded during the year to key management personnel and no options vested during the year.<br />

Performance Rights granted during the year to key management personnel<br />

1,450,000 ECRS Rights were awarded to key management personnel during the year, of which nil vested.<br />

Remuneration of key management personnel<br />

Aggregates <strong>2012</strong><br />

$<br />

2011<br />

$<br />

Short-Term Benefi ts 1,645,236 1,568,076<br />

Post-Employment 135,780 1<strong>15</strong>,125<br />

Share Based Payment 238,440 95,119<br />

Termination <strong>15</strong>,508 275,742<br />

Totals 2,034,964 2,054,062<br />

DIRECTOR’S REPORT

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!